Therefore, the upregulation of Cx43, which is observed in AD brains, may start as a neuroprotective response to amyloid plaques and explain clinical studies showing increased neuronal activity in the hippocampus and cortex in non-demented individuals at high risk for AD or at presymptomatic stage of familial AD [517,518]. This evidence concerns the gene GJA1 and Alzheimer disease.